Rhabdoid Carcinoma Open Access Journals
Rhabdoid
tumor may be a rare, highly aggressive
malignancy that primarily affects infants and young children. These
tumors typically arise within the
brain and kidney, although extrarenal, non–central systema nervosum
tumors in most soft-tissue sites are described. SMARCB1 may be a member of the SWI/SNF chromatin-remodeling complex and functions as a
tumor suppressor within the overwhelming majority of rhabdoid tumors. Patients with germline
mutations or deletions affecting SMARCB1 are predisposed to the event of rhabdoid tumors, also because the genetic disease schwannomatosis. the present hypothesis is that rhabdoid
tumors are driven by epigenetic dysregulation, as against the alteration of a selected biologic pathway. The strategies for novel therapeutic approaches supported what's currently known about rhabdoid
tumor biology are presented.Rhabdoid
tumor (RT) may be a rare and highly malignant neoplasm that arises predominantly within the
brain (referred to as atypical teratoid/RT [AT/RT]), kidney (RT of the kidney [RTK]), or soft
tissues (extrarenal RT, malignant RT [MRT]). Frequent sites for extrarenal RTs include the skin, liver, and lung, although
tumors in most soft tissues, including the orbit, thymus, uterus, bladder, and neck, are reported. the height incidence is between 1 and 4 years aged , although classic RTs in adults are described.
High Impact List of Articles
Relevant Topics in Clinical